AptarGroup Inc (ATR)
Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell
$120.00
Buy
$134.35
$-0.74 (-0.58%)
Prices updated at 02 Apr 2026, 23:27 EDT
| Prices minimum 15 mins delay
Prices in USD
AptarGroup, Inc. is a solution provider of packaging delivery solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 3,583m | 3,777m | |
| 1,356m | 1,405m | |
| 509m | 511m | |
| 14.22 | 13.53 | |
| 375m | 393m | |
| 777m | 831m | |
| Sales, General and administrative | 582m | 606m |
| Interest expenses | 44m | 53m |
| Provision for income taxes | 96m | 99m |
| Operating expenses | 846m | 894m |
| Income before taxes | 470m | 491m |
| Net income available to common shareholders | 375m | 393m |
| 5.65 | 5.97 | |
| Net interest income | -32m | -41m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 5.53 | 5.89 |
| Free cash flow per share | 5.5993 | 4.549 |
| Book value/share | 38.1806 | 43.1333 |
| Debt equity ratio | 0.298469 | 0.445026 |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | 1,478m | 1,894m |
| Current liabilities | 1,068m | 1,166m |
| Total capital | 3,160m | 3,808m |
| Total debt | 1,076m | 1,531m |
| Total equity | 2,472m | 2,668m |
| Total non current liabilities | - | - |
| Loans | 688m | 1,139m |
| Total assets | 4,432m | 5,253m |
| Total liabilities | - | - |
| Cash and cash equivalents | 224m | 402m |
| Common stock | 67m | 64m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 224m | 224m |
| Cash dividends paid | -114m | -121m |
| 349m | 295m | |
| Investments (gains) losses | -397m | -331m |
| 224m | 405m | |
| Net income | - | - |
| 643m | 570m | |
| -294m | -275m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.